Transfusion-Transmissible Infections Monitoring System (TTIMS) Laboratory & Risk Factor Database Coordinating Center (LRCC)

Closed Solicitation Posted

Solicitation number
FDARFP1238397
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Silver Spring, Maryland 20993, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research seeks to procure a Transfusion-Transmissible Infections Monitoring System Laboratory and Risk Factor Database Coordinating Center through Solicitation Number FDA-RFP-1238397. The selected contractor will coordinate laboratory testing and data collection and management to monitor transfusion-transmissible infections and related risk factors. Proposals will be evaluated based on technical capability, past performance, and price. The deadline for proposal submission is September 7, 2021.

There is no set-aside designation. The primary NAICS code is 541715 and PSC code R425. The incumbent contractor is not named. The contract is a firm-fixed-price award with one base year and four one-year options to be performed in Silver Spring, Maryland. Offerors must demonstrate meeting small business subcontracting goals and provide past performance references. The Statement of Work specifies monthly, quarterly, and annual reporting requirements.

Notice text

3 versions

Update #3 · Latest ·

The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection (TTI) Monitoring System (TTIMS) Laboratory and Risk Factor Database Coordinating Center (LRCC).

See Attachments for Solicitation, Statement of Work and related documents

See Attachments for Government Responses to Contractors Questions

Update #2 ·

The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection (TTI) Monitoring System (TTIMS) Laboratory and Risk Factor Database Coordinating Center (LRCC).

See Attachments for Solicitation, Statement of Work and related documents

See Attachment for Government Responses to Contractors Questions

Update #1 ·

The U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), has a requirement for a Transfusion-Transmissible Infection (TTI) Monitoring System (TTIMS) Laboratory and Risk Factor Database Coordinating Center (LRCC).

See Attachments for Solicitation, Statement of Work and related documents

Files

Similar open opportunities

Opportunity Agency Set-aside Responses due
BPA - Blood Transfusion Services Wright Patterson AFB, Ohio 45433, United States · NAICS 621991 AFLCMC Wright Patterson AFB No set-aside
BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems Jbsa Ft Sam Houston, Texas 78234, United States · NAICS 325413 Defense Health Agency Service-Disabled Veteran-Owned Small Business

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity